Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Use of Biocellular and cellular approaches to treatment of Osteoarthritis (OA),
musculoskeletal aging processes, pain, and degenerative changes are to be studied with
minimally invasive protocols, and non-pharmaceutical means to relieve OA and its associated
issues. Traditional surgical interventions have not yielded convincing long-term outcomes,
including total joint replacement surgeries and medical management of the supportive
structures.
This study is to use a person's own stem/stromal Cells (autologous) plus HD-PRP (important
healing growth factors and signal molecules) in such cases of OA for long-term minimally
invasive treatments. Baseline (existing) findings are documented, and thence tracked as to
progress deemed to be result of the intervention.
Phase:
N/A
Details
Lead Sponsor:
Healeon Medical Inc
Collaborators:
Donna Alderman, DO Robert W. Alexander, MD Terry, Glenn C., M.D.